Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03112343
What this trial is testing

Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment

Who this might be right for
Diabetes MellitusInsulin HypoglycemiaInsulin-dependent Diabetes Mellitus
Samsung Medical Center 112
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT01286350
What this trial is testing

FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)

Who this might be right for
Type 1 Diabetes
University of North Carolina, Chapel Hill 258
Early research (Phase 1)Study completedNCT03411915
What this trial is testing

XmAb®18087 in Subjects With NET and GIST

Who this might be right for
Neuroendocrine TumorGastrointestinal Neoplasm
Xencor, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT01103817
What this trial is testing

Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
The Hospital for Sick Children 33
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Early research (Phase 1)Study completedNCT02018315
What this trial is testing

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

Who this might be right for
Glucose Transporter Type 1 Deficiency SyndromeGLUT1 Deficiency Syndrome
Juan Pascual 14
Large-scale testing (Phase 3)Study completedNCT02670915
What this trial is testing

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 834
Large-scale testing (Phase 3)Study completedNCT04049110
What this trial is testing

Dapagliflozin in Physical Exercise in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Insel Gruppe AG, University Hospital Bern 39
Not applicableStudy completedNCT05933460
What this trial is testing

Crocus Sativus Extract Impact in Metabolic Control of Patients With Diabetes Mellitus Type 1

Who this might be right for
Diabetes Mellitus, Type 1Diabetes type1
Aristotle University Of Thessaloniki 61
Early research (Phase 1)Study completedNCT03310944
What this trial is testing

Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
Sanofi 12
Early research (Phase 1)Looking for participantsNCT07025564
What this trial is testing

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 20
Early research (Phase 1)Study completedNCT02202993
What this trial is testing

TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme (GBM)
Cavion, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT01061216
What this trial is testing

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 20
Not applicableStudy completedNCT00004875
What this trial is testing

Heparin or Enoxaparin in Patients With Cancer

Who this might be right for
LymphomaThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Post-approval studies (Phase 4)Not Yet RecruitingNCT04698330
What this trial is testing

Effects Of Berberine Plus Inulin On Diabetes Care in Patients With LADA

Who this might be right for
Type 1 Diabetes MellitusAutoimmune Diabetes
Second Xiangya Hospital of Central South University 240
Large-scale testing (Phase 3)Study completedNCT03738865
What this trial is testing

G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes

Who this might be right for
Insulin HypoglycemiaType 1 Diabetes MellitusSevere Hypoglycemia
Xeris Pharmaceuticals 132
Early research (Phase 1)Study completedNCT01784211
What this trial is testing

LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Eli Lilly and Company 76
Next Page